Insufficient scRNA-seq data for expression of WNT9A at single-cell level.
Insufficient scRNA-seq data for expression of WNT9A at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
uterus | 98% | 1566.04 | 166 / 170 | 90% | 12.49 | 412 / 459 |
lung | 96% | 829.07 | 553 / 578 | 85% | 9.56 | 976 / 1155 |
thymus | 93% | 427.94 | 608 / 653 | 84% | 5.39 | 509 / 605 |
ovary | 99% | 1878.81 | 179 / 180 | 77% | 5.52 | 333 / 430 |
breast | 82% | 637.21 | 378 / 459 | 91% | 10.76 | 1021 / 1118 |
prostate | 87% | 497.89 | 214 / 245 | 84% | 4.43 | 421 / 502 |
esophagus | 100% | 1829.28 | 1438 / 1445 | 69% | 9.55 | 126 / 183 |
bladder | 95% | 990.00 | 20 / 21 | 62% | 5.23 | 310 / 504 |
pancreas | 77% | 271.73 | 251 / 328 | 78% | 5.76 | 138 / 178 |
intestine | 95% | 2332.73 | 922 / 966 | 33% | 1.69 | 176 / 527 |
stomach | 79% | 999.18 | 285 / 359 | 37% | 2.29 | 105 / 286 |
tonsil | 0% | 0 | 0 / 0 | 100% | 13.54 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 3.89 | 1 / 1 |
muscle | 100% | 2938.22 | 801 / 803 | 0% | 0 | 0 / 0 |
adrenal gland | 57% | 222.74 | 146 / 258 | 29% | 1.30 | 66 / 230 |
adipose | 72% | 456.41 | 863 / 1204 | 0% | 0 | 0 / 0 |
kidney | 26% | 88.15 | 23 / 89 | 46% | 2.41 | 412 / 901 |
heart | 64% | 426.37 | 552 / 861 | 0% | 0 | 0 / 0 |
brain | 24% | 77.43 | 624 / 2642 | 28% | 1.36 | 197 / 705 |
skin | 35% | 115.36 | 634 / 1809 | 14% | 1.09 | 66 / 472 |
spleen | 47% | 151.96 | 113 / 241 | 0% | 0 | 0 / 0 |
blood vessel | 35% | 121.99 | 469 / 1335 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 31% | 2.02 | 9 / 29 |
liver | 1% | 5.52 | 3 / 226 | 12% | 1.17 | 49 / 406 |
peripheral blood | 0% | 0.52 | 2 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0071300 | Biological process | cellular response to retinoic acid |
GO_0032331 | Biological process | negative regulation of chondrocyte differentiation |
GO_0030182 | Biological process | neuron differentiation |
GO_0008285 | Biological process | negative regulation of cell population proliferation |
GO_0061072 | Biological process | iris morphogenesis |
GO_0072498 | Biological process | embryonic skeletal joint development |
GO_0045165 | Biological process | cell fate commitment |
GO_0061303 | Biological process | cornea development in camera-type eye |
GO_0060070 | Biological process | canonical Wnt signaling pathway |
GO_0005615 | Cellular component | extracellular space |
GO_0005576 | Cellular component | extracellular region |
GO_0005109 | Molecular function | frizzled binding |
GO_0005515 | Molecular function | protein binding |
GO_0005125 | Molecular function | cytokine activity |
GO_0048018 | Molecular function | receptor ligand activity |
Gene name | WNT9A |
Protein name | Protein Wnt-9a (Protein Wnt-14) Protein Wnt |
Synonyms | WNT14 |
Description | FUNCTION: Ligand for members of the frizzled family of seven transmembrane receptors. Functions in the canonical Wnt/beta-catenin signaling pathway. Required for normal timing of IHH expression during embryonic bone development, normal chondrocyte maturation and for normal bone mineralization during embryonic bone development. Plays a redundant role in maintaining joint integrity. . FUNCTION: Ligand for members of the frizzled family of seven transmembrane receptors. . |
Accessions | ENST00000272164.6 D9ZGG3 O14904 |